3rd Quarter - Amendment

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$620,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2018 $510,000 Replaced
3rd Quarter - Amendment (this page) May 2, 2019 $620,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Coverage Gap Discount Cancer Care Payment Reform Act (S 463, H 1834) Oncology Care Model - CMS

LobbyistCovered position, as disclosed
SUSIE AHN —
CHRISTINE BLOOMQUIST —
MORGAN BRADLEY-JONES —
HELEN DWIGHT —
NATALIE MORRIS —
LAURA OKPALA —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Health Issues HCR

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

LobbyistCovered position, as disclosed
SUSIE AHN —
CHRISTINE BLOOMQUIST —
MORGAN BRADLEY-JONES —
HELEN DWIGHT —
THERESA JOLIVETTE —
NATALIE MORRIS —
LAURA OKPALA —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1628 (115th)

Pharmacy PHA

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

LobbyistCovered position, as disclosed
SUSIE AHN —
CHRISTINE BLOOMQUIST —
MORGAN BRADLEY-JONES —
HELEN DWIGHT —
THERESA JOLIVETTE —
NATALIE MORRIS —
LAURA OKPALA —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5773 (115th), S. 251 (115th), H.R. 4841 (115th), S. 870 (115th), H.R. 2550 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.